Related Experiment Video
Updated: Feb 6, 2026

Capsular Serotyping of Streptococcus pneumoniae Using the Quellung Reaction
Published on: February 24, 2014
Perinatal Streptococcus agalactiae Epidemiology and Surveillance Targets
Lucy L Furfaro1, Barbara J Chang2, Matthew S Payne3
1School of Medicine, Division of Obstetrics and Gynaecology, The University of Western Australia, Crawley, Australia lucy.furfaro@uwa.edu.au.
Insights
Group B Streptococcus (GBS) is a major neonatal pathogen. Understanding GBS epidemiology and strain diversity is crucial for developing effective vaccines and therapeutics to combat neonatal infections.
Area of Science:
- Microbiology
- Epidemiology
- Infectious Diseases
Background:
- Group B Streptococcus (GBS) is a significant cause of neonatal infections globally.
- While maternal and neonatal colonization prevalence is increasingly understood, epidemiological gaps persist.
- Effective GBS strain classification is essential for accurate epidemiological surveillance.
Purpose of the Study:
- To review current GBS epidemiological classification schemes.
- To identify key targets for epidemiological surveillance of GBS.
- To highlight the importance of detailed GBS strain information for therapeutic development and monitoring.
Main Methods:
- Review of existing literature on GBS classification and epidemiology.
- Analysis of phenotypic and genotypic classification methods.
- Discussion of current global screening practices for GBS.
Main Results:
- Various phenotypic and genotypic methods exist for GBS strain classification, with varying discriminatory power.
- Current GBS screening offers opportunities for detailed strain data collection.
- Identifying circulating strains and targets in invasive GBS is critical for surveillance.
Conclusions:
- A comprehensive understanding of GBS epidemiology is vital for pathogenesis research.
- Detailed GBS strain surveillance is crucial for monitoring vaccine and therapeutic efficacy.
- Enhanced epidemiological data will inform future prevention strategies against GBS.
Abstract:
Streptococcus agalactiae, or group B streptococcus (GBS), is a major neonatal pathogen. Recent data have elucidated the global prevalence of maternal and neonatal colonization, but gaps still remain in the epidemiology of this species. A number of phenotypic and genotypic classifications can be used to identify the diversity of GBS strains, and some are more discriminatory than others. This review explores the main schemes used for GBS epidemiology and further details the targets for epidemiological surveillance. Current screening practices across the world provide a unique opportunity to gain detailed information on maternal colonizing strains and neonatal disease-causing strains, which is vital for monitoring and therapeutics, if sufficient detail can be extracted. Deciphering which isolates are circulating within specific populations and recording targets within invasive strains are crucial steps in monitoring the implementation of therapeutics, such as vaccines, as well as developing novel therapies against prevalent GBS strains. Having a detailed understanding of global GBS epidemiology will prove invaluable for understanding the pathogenesis of this organism and equipping future prevention strategies for success.
Related Concept Videos
Introduction to Epidemiology
Causality in Epidemiology
Principles of Disease Surveillance
Study Designs in Epidemiology
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
Confounding in Epidemiological Studies
Bias in Epidemiological Studies

